reymond marc (32 resultados)

Hardcover. Condición: Sehr gut. XV, 136 S. : Ill.; 27,5 cm, Very good. Shrink wrapped. Sprache: Englisch Gewicht in Gramm: 790.

Hardcover. Condición: As New. Leichte Kratzer / Abnutzungen / Druckstellen. This is the most talked about subject in laparoscopic surgery today. At every meeting in surgery and oncology at least one or two sections involve this topic. This book allows the reader an organized insight into the different pathogenic mechanisms of port-site recurrences, notably as to where the cells from which the secondary tumour arises come from, how they are dispersed, and how local effects in the port-site wound can favor implantation. Moreover, the book contains practical well illustrated guidelines to show preventive measures applicable by any surgeon. These can reduce substantially the incidence of port-site recurrence, allowing for a safer application of minimally invasive surgery in cancer. All or most surgical units working in this field world wide have contributed to this book.

In-8 ( 210 X 140 mm ) de 125 pages, broché sous couverture illustrée. Très bel exemplaire. Esotérisme Occultisme Hermétisme Symbolisme Religion Franc-Maçonnerie.

Condición: Bon. Livre 1998, La nef de Salomon, in-8 broché de 125 pages, Le plan secret d'Hiram, fondements opératifs et perspectives spéculatives du tableau de loge | Etat : bon état, couverture un peu défraîchie, quelques pages cornées, annotations et passages surlignés (Ref.: ref86616). Livre.

in-8, br., neuf, LETTRE D'ENVOI DE L'AUTEUR AU PROFESSEUR R. DE BOTTINI, 369p.

Condición: new.

Condición: As New. Unread book in perfect condition.

Condición: New.

Condición: New.

Condición: As New. Unread book in perfect condition.

Hardcover. Condición: Brand New. 252 pages. 6.29x9.44x0.63 inches. In Stock.

Condición: New. In.

Condición: New.

Buch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - Peritoneal dissemination is a common route of cancer metastasis. The benefit of administering chemotherapy directly into the peritoneal cavity is supported by preclinical and pharmacokinetic data. In comparison to intravenous (IV) treatment, intraperitoneal (IP) administration results in a several-fold increase in drug concentration within the abdominal cavity. There is now growing evidence from clinical studies showing a survival advantage for IP chemotherapy in various tumor typies, including ovarian, gastric and colorectal cancer.However, while the use of IP chemotherapy is slowly gaining acceptance, it is not universal, largely due to the greater toxicity associated with this approach. Moreover, efficacy of IP chemotherapy is limited by poor distribution within the abdominal cavity and by poor tissue penetration. A new way of IP chemotherapy is the application of cytotoxics in form of a pressurized aerosol into the abdominal of thoracic cavity. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is applied through laparoscopic access using two balloon trocars in an operating room equipped with laminar air-flow. In a first step,a normothermic capnoperitoneum is established with a pressure of 12 mmHg. A cytotoxic solution (about 10% of a normal systemic dose) is nebulized with a micropump into the abdominal cavity, and maintained for 30 min. The aerosol is then removed through a closed suction system. Applying an aerosol in the peritoneal cavity allows a homogeneous distribution of the chemotherapeutic agent within the abdomen. Furthermore, an artificial pressure gradient is generated that overcomes tumoral interstitial fluid pressure, an obstacle in cancer therapy. This results in a higher local drug concentration compared to conventional IP or IV chemotherapy. At the same time the plasma concentration of the chemotherapeutic agent remains low. In first clinical studies with limited number of patients in ovarian, gastric and colorectal cancer, as well as peritoneal mesothelioma, PIPAC has obtained encouraging tumor response rates and survival, with a low-side effects profile. Larger clinical trials are currently ongoing to examine if these data can be reproduced and extrapolated to other situations.

Condición: New.

Condición: New. 2014. Hardcover. . . . . .

Hardback. Condición: New. 1st. Peritoneal dissemination is a common route of cancer metastasis. The benefit of administering chemotherapy directly into the peritoneal cavity is supported by preclinical and pharmacokinetic data. In comparison to intravenous (IV) treatment, intraperitoneal (IP) administration results in a several-fold increase in drug concentration within the abdominal cavity. There is now growing evidence from clinical studies showing a survival advantage for IP chemotherapy in various tumor typies, including ovarian, gastric and colorectal cancer.However, while the use of IP chemotherapy is slowly gaining acceptance, it is not universal, largely due to the greater toxicity associated with this approach. Moreover, efficacy of IP chemotherapy is limited by poor distribution within the abdominal cavity and by poor tissue penetration. A new way of IP chemotherapy is the application of cytotoxics in form of a pressurized aerosol into the abdominal of thoracic cavity. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is applied through laparoscopic access using two balloon trocars in an operating room equipped with laminar air-flow. In a first step,a normothermic capnoperitoneum is established with a pressure of 12 mmHg. A cytotoxic solution (about 10% of a normal systemic dose) is nebulized with a micropump into the abdominal cavity, and maintained for 30 min. The aerosol is then removed through a closed suction system. Applying an aerosol in the peritoneal cavity allows a homogeneous distribution of the chemotherapeutic agent within the abdomen. Furthermore, an artificial pressure gradient is generated that overcomes tumoral interstitial fluid pressure, an obstacle in cancer therapy. This results in a higher local drug concentration compared to conventional IP or IV chemotherapy. At the same time the plasma concentration of the chemotherapeutic agent remains low. In first clinical studies with limited number of patients in ovarian, gastric and colorectal cancer, as well as peritoneal mesothelioma, PIPAC has obtained encouraging tumor response rates and survival, with a low-side effects profile. Larger clinical trials are currently ongoing to examine if these data can be reproduced and extrapolated to other situations.

Hardback. Condición: New. 1st. Peritoneal dissemination is a common route of cancer metastasis. The benefit of administering chemotherapy directly into the peritoneal cavity is supported by preclinical and pharmacokinetic data. In comparison to intravenous (IV) treatment, intraperitoneal (IP) administration results in a several-fold increase in drug concentration within the abdominal cavity. There is now growing evidence from clinical studies showing a survival advantage for IP chemotherapy in various tumor typies, including ovarian, gastric and colorectal cancer.However, while the use of IP chemotherapy is slowly gaining acceptance, it is not universal, largely due to the greater toxicity associated with this approach. Moreover, efficacy of IP chemotherapy is limited by poor distribution within the abdominal cavity and by poor tissue penetration. A new way of IP chemotherapy is the application of cytotoxics in form of a pressurized aerosol into the abdominal of thoracic cavity. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is applied through laparoscopic access using two balloon trocars in an operating room equipped with laminar air-flow. In a first step,a normothermic capnoperitoneum is established with a pressure of 12 mmHg. A cytotoxic solution (about 10% of a normal systemic dose) is nebulized with a micropump into the abdominal cavity, and maintained for 30 min. The aerosol is then removed through a closed suction system. Applying an aerosol in the peritoneal cavity allows a homogeneous distribution of the chemotherapeutic agent within the abdomen. Furthermore, an artificial pressure gradient is generated that overcomes tumoral interstitial fluid pressure, an obstacle in cancer therapy. This results in a higher local drug concentration compared to conventional IP or IV chemotherapy. At the same time the plasma concentration of the chemotherapeutic agent remains low. In first clinical studies with limited number of patients in ovarian, gastric and colorectal cancer, as well as peritoneal mesothelioma, PIPAC has obtained encouraging tumor response rates and survival, with a low-side effects profile. Larger clinical trials are currently ongoing to examine if these data can be reproduced and extrapolated to other situations.

Condición: New. 2014. Hardcover. . . . . . Books ship from the US and Ireland.

Condición: gut. 369 S., 23 cm, Vorblatt mit Bleistiftanmerkung. Sprache: Französisch.

hardcover. Condición: Sehr gut. 880 Seiten; Sprache: Deutsch Gewicht in Gramm: 3.

Gr.-8°. illustrierte OPappe., Condición: Wie neu. 1. Auflage.,. Mit 1018 Abbildungen., 739 Seiten., Gutes Exemplar. Sprache: Deutsch Gewicht in Gramm: 2100.

Condición: gut. Le projet de code de procédure civile fédérale In deutscher Sprache. pages.

Condición: Sehr gut. 3. Aufl. 688 S. Als Mängelexemplar gekennzeichnet, Lagerspuren vorhanden Sprache: Deutsch Gewicht in Gramm: 1313.

Paperback. Condición: Brand New. German language. 9.69x6.85x1.18 inches. In Stock.

Broschiert. Condición: Sehr gut. 688 Seiten Archivexemplar mit Aufkleber auf dem Buchrücken, Auflage 2022 - Leichte äußere Mängel - Buch ist als Mängelexemplar gekennzeichnet - Buch ansonsten in sehr gutem Zustand - Jeder Lieferung liegt eine ordentliche Rechnung mit ausgewiesener MwSt. bei Sprache: Deutsch Gewicht in Gramm: 1510.

Hardcover. Condición: gut. Auflage: 1., Aufl. (15. Mai 2003). Kompaktatlas Chirurgie Marc A. Reymond Rainer Kirchner Hans Lippert Urban & Fischer bei Elsevier Operationstechniken In deutscher Sprache. 700 pages. 24,7 x 18,4 x 4 cm.

Hardcover. Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Peritoneal dissemination is a common r.

Buch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Peritoneal dissemination is a common route of cancer metastasis. The benefit of administering chemotherapy directly into the peritoneal cavity is supported by preclinical and pharmacokinetic data. In comparison to intravenous (IV) treatment, intraperitoneal (IP) administration results in a several-fold increase in drug concentration within the abdominal cavity. There is now growing evidence from clinical studies showing a survival advantage for IP chemotherapy in various tumor typies, including ovarian, gastric and colorectal cancer.However, while the use of IP chemotherapy is slowly gaining acceptance, it is not universal, largely due to the greater toxicity associated with this approach. Moreover, efficacy of IP chemotherapy is limited by poor distribution within the abdominal cavity and by poor tissue penetration. A new way of IP chemotherapy is the application of cytotoxics in form of a pressurized aerosol into the abdominal of thoracic cavity. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is applied through laparoscopic access using two balloon trocars in an operating room equipped with laminar air-flow. In a first step,a normothermic capnoperitoneum is established with a pressure of 12 mmHg. A cytotoxic solution (about 10% of a normal systemic dose) is nebulized with a micropump into the abdominal cavity, and maintained for 30 min. The aerosol is then removed through a closed suction system. Applying an aerosol in the peritoneal cavity allows a homogeneous distribution of the chemotherapeutic agent within the abdomen. Furthermore, an artificial pressure gradient is generated that overcomes tumoral interstitial fluid pressure, an obstacle in cancer therapy. This results in a higher local drug concentration compared to conventional IP or IV chemotherapy. At the same time the plasma concentration of the chemotherapeutic agent remains low. In first clinical studies with limited number of patients in ovarian, gastric and colorectal cancer, as well as peritoneal mesothelioma, PIPAC has obtained encouraging tumor response rates and survival, with a low-side effects profile. Larger clinical trials are currently ongoing to examine if these data can be reproduced and extrapolated to other situations. 252 pp. Englisch.

Gebunden. Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Priv.-Doz. Dr. med. Marc A. Reymond Hochschullehrer und Oberarzt der Klinik f&uumlr Allgemein-, Viszeral- und Gef&auml&szligchirurgie, Otto-von-Guericke-Universit&aumlt, Magdeburg Dr. med. Rainer Kirchner Funktionsoberarzt der Orthop&auml.